Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Actinium PharmaceuticalsMereo BioPharma GroupFaron Pharmaceuticals OyNuformixAerpio Pharmaceuticals
SymbolNYSEAMERICAN:ATNMN/ALON:FARNLON:NFXNYSE:ARPO
Price Information
Current Price$0.2020N/AGBX 109.50GBX 9.15$0.64
52 Week RangeBuyN/AN/AN/ABuy
Analyst Ratings
Consensus RecommendationBuyN/AN/AN/ABuy
Consensus Price Target$4.6667N/AN/AN/AN/A
% Upside from Price Target2,210.23% upsideN/AN/AN/AN/A
Trade Information
Market Cap$33.30 million£64.65 million£41.81 million£42.16 million$25.57 million
BetaN/AN/AN/AN/AN/A
Average Volume1,100,27126614,5011,130,000311,735
Sales & Book Value
Annual RevenueN/AN/AN/A£610,000.00N/A
Price / SalesN/AN/AN/A69.11N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/A1.79N/AN/AN/A
Book ValueN/AGBX 46 per shareGBX 25.10 per shareGBX 0.80 per shareN/A
Price / BookN/AN/AN/A0.11N/A
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSN/AGBX (45)GBX (109.50)GBX (0.40)N/A
Trailing P/E Ratio0.00N/AN/AN/A0.00
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A65.56%577.78%0.40%N/A
Current RatioN/A2.13%1.19%0.42%N/A
Quick RatioN/A2.05%0.87%0.41%N/A
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees3031183N/A
Shares Outstanding162.43 million97.96 million38.18 million460.75 million40.59 million
Next Earnings Date11/8/2019 (Estimated)N/AN/AN/A11/6/2019 (Estimated)
OptionableOptionableNot OptionableNot OptionableOptionableNot Optionable
 Actinium PharmaceuticalsMereo BioPharma GroupFaron Pharmaceuticals OyNuformixAerpio Pharmaceuticals

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel